Vasculitis of the upper and lower airway

Best Practice and Research: Clinical Rheumatology

Volumn 23, Issue 3, 2009, Pages 403-417

  Del Pero, M Martinez ^a   Sivasothy, P ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

airway stenosis; asthma; Churg Strauss syndrome; microscopic polyangittis; upper airway; Wegener's granulomatosis

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN E ANTIBODY; INFLIXIMAB; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHOTREXATE; MITOMYCIN; MYCOPHENOLIC ACID; PREDNISOLONE; RITUXIMAB; STEROID;

ACUTE DISEASE; AIRWAY OBSTRUCTION; ANCA ASSOCIATED VASCULITIS; BRONCHOSCOPY; CHRONIC DISEASE; CHURG STRAUSS SYNDROME; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; EAR DISEASE; HEAD; HUMAN; LARYNX; LOWER RESPIRATORY TRACT; LUNG FUNCTION TEST; LUNG HEMORRHAGE; MEDICAL ASSESSMENT; MICROSCOPIC POLYANGIITIS; NECK; NOSE DISEASE; OROPHARYNX; PRIORITY JOURNAL; PULMONARY VASCULITIS; REVIEW; SYMPTOM; THORAX RADIOGRAPHY; UPPER RESPIRATORY TRACT; WEGENER GRANULOMATOSIS;

AIRWAY OBSTRUCTION; ASTHMA; CHURG-STRAUSS SYNDROME; HUMANS; MICROVESSELS; RESPIRATORY TRACT DISEASES; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 66349112086     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2009.02.003     Document Type: Review

References (83)

1. Watts R.S. Epidemiology of the vasculitides. Semin Respir Crit Care Med (2005)
2. Lane S., Watts R., Shepstone L., et al. Primary systemic vasculitis: clinical features and mortality. QJM 98 (2005) 97-111
3. Mahr A., Neogi T., and Merkel P. Epidemiology of Wegener's granulomatosis: lessons from descriptive studies and analyses of genetic and environmental risk determinants. Clin Exp Rheumatol 24 (2006) S82-S91
4. Ranes J., and Stoller J. A review of alpha-1 antitrypsin deficiency. Semin Respir Crit Care Med 26 (2005) 154-166
5. Mcdonald T., and Deremee R. Wegener's granulomatosis. Laryngoscope 93 (1983) 220-231
6. Rasmussen N. Management of the ear, nose, and throat manifestations of Wegener granulomatosis: an otorhinolaryngologist's perspective. Curr Opin Rheumatol 13 (2001) 3-11
7. Sproson E., Jones N., Al-Deiri M., et al. Lessons learnt in the management of Wegener's Granulomatosis: long-term follow-up of 60 patients. Rhinology 45 (2007) 63-67
8. Ahmad I., Lee W., Nagendran V., et al. Localised Wegener's granulomatosis in otolaryngology: a review of six cases. ORL J Otorhinolaryngol Relat Spec 62 (2000) 149-155
9. Burlacoff S., and Wong F. Wegener's granulomatosis. The great masquerade: a clinical presentation and literature review. J Otolaryngol 22 (1993) 94-105
10. Bakthavachalam S., Driver M., Cox C., et al. Hearing loss in Wegener's granulomatosis. Otol Neurotol 25 (2004) 833-837
11. Illum P., and Thorling K. Otological manifestations of Wegener's granulomatosis. Laryngoscope 92 (1982) 801-804
12. Seo P., Min Y., Holbrook J., et al. Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET). Arthritis Rheum 52 (2005) 2168-2178
13. Stewart C., Cohen D., Bhattacharyya I., et al. Oral manifestations of Wegener's granulomatosis: a report of three cases and a literature review. J Am Dent Assoc 138 (2007) 338-348 quiz 396, 398
14. Delplace D., Da Costa L., Goffin L., et al. Oral ulceration: an unusual manifestation of Churg-Strauss syndrome. J Eur Acad Dermatol Venereol 21 (2007) 969-972
15. Gottschlich S., Ambrosch P., Kramkowski D., et al. Head and neck manifestations of Wegener's granulomatosis. Rhinology 44 (2006) 227-233
16. Solans-Laque R., Bosch-Gil J., Canela M., et al. Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis. Lupus 17 (2008) 832-836
17. Seo P. Wegener's granulomatosis: managing more than inflammation. Curr Opin Rheumatol 20 (2008) 10-16
18. Erickson V., and Hwang P. Wegener's granulomatosis: current trends in diagnosis and management. Curr Opin Otolaryngol Head Neck Surg 15 (2007) 170-176
19. Frosch M., and Foell D. Wegener granulomatosis in childhood and adolescence. Eur J Pediatr 163 (2004) 425-434
20. Belostostky V., Shah V., and Dillon M. Clinical features in 17 paediatric patients with Wegener granulomatosis. Pediatr Nephrol 17 (2002) 754-761
21. Rottem M., Fauci A., Hallahan C., et al. Wegener granulomatosis in children and adolescents: clinical presentation and outcome. J Pediatr 122 (1993) 26-31
22. Akikusa J., Schneider R., Harvey E., et al. Clinical features and outcome of pediatric Wegener's granulomatosis. Arthritis Rheum 57 (2007) 837-844
23. Cuellar M., and Espinoza L. Laboratory testing in the evaluation and diagnosis of vasculitis. Curr Rheumatol Rep 2 (2000) 417-422
24. Hellmich B., Flossmann O., Gross W., et al. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 66 (2007) 605-617
25. Lurati-Ruiz F., and Spertini F. Predictive value of antineutrophil cytoplasmic antibodies in small-vessel vasculitis. J Rheumatol 32 (2005) 2167-2172
26. Wiik A. Rational use of ANCA in the diagnosis of vasculitis. Rheumatology (Oxford) 41 (2002) 481-483
27. Sinico R., Di Toma L., Maggiore U., et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 52 (2005) 2926-2935
28. Guillevin L., Pagnoux C., and Mouthon L. Churg-strauss syndrome. Semin Respir Crit Care Med 25 (2004) 535-545
29. Stegeman C., Tervaert J., Sluiter W., et al. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 120 (1994) 12-17
30. Murray A., and Mcgarry G. The clinical value of septal perforation biopsy. Clin Otolaryngol Allied Sci 25 (2000) 107-109
31. Diamantopoulos I., and Jones N. The investigation of nasal septal perforations and ulcers. J Laryngol Otol 115 (2001) 541-544
32. Prior A., Calderon M., Lavelle R., et al. Nasal biopsy: indications, techniques and complications. Respir Med 89 (1995) 161-169
33. Anderson G., Coles E., Crane M., et al. Wegener's granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee. Q J Med 83 (1992) 427-438
34. Jennings C., Jones N., Dugar J., et al. Wegener's granulomatosis-a review of diagnosis and treatment in 53 subjects. Rhinology 36 (1998) 188-191
35. Lohrmann C., Uhl M., Warnatz K., et al. Sinonasal computed tomography in patients with Wegener's granulomatosis. J Comput Assist Tomogr 30 (2006) 122-125
36. Allen S., and Harvey C. Imaging of Wegener's granulomatosis. Br J Radiol 80 (2007) 757-765
37. Lloyd G., Lund V., Beale T., et al. Rhinologic changes in Wegener's granulomatosis. J Laryngol Otol 116 (2002) 565-569
38. Muhle C., Reinhold-Keller E., Richter C., et al. MRI of the nasal cavity, the paranasal sinuses and orbits in Wegener's granulomatosis. Eur Radiol 7 (1997) 566-570
39. Jayne D. How to induce remission in primary systemic vasculitis. Best Pract Res Clin Rheumatol 19 (2005) 293-305
40. De Groot K., Rasmussen N., Bacon P., et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 52 (2005) 2461-2469
41. Deremee R. The treatment of Wegener's granulomatosis with trimethoprim/sulfamethoxazole: illusion or vision?. Arthritis Rheum 31 (1988) 1068-1074
42. Stegeman C., Tervaert J., De Jong P., et al. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med 335 (1996) 16-20
43. Srouji I., Andrews P., Edwards C., et al. General and rhinosinusitis-related quality of life in patients with Wegener's granulomatosis. Laryngoscope 116 (2006) 1621-1625
44. Takagi D., Nakamaru Y., Maguchi S., et al. Otologic manifestations of Wegener's granulomatosis. Laryngoscope 112 (2002) 1684-1690
45. Nouraei S., Obholzer R., Ind P., et al. Results of endoscopic surgery and intralesional steroid therapy for airway compromise due to tracheobronchial Wegener's granulomatosis. Thorax 63 (2008) 49-52
46. Abou-Elhmd K., Hawthorne M., and Flood L. Cochlear implantation in a case of Wegener's granulomatosis. J Laryngol Otol 110 (1996) 958-961
47. Congdon D., Sherris D., Specks U., et al. Long-term follow-up of repair of external nasal deformities in patients with Wegener's granulomatosis. Laryngoscope 112 (2002) 731-737
48. Daum T., Specks U., Colby T., et al. Tracheobronchial involvement in Wegener's granulomatosis. Am J Respir Crit Care Med 151 (1995) 522-526
49. Brown K. Pulmonary vasculitis. Proc Am Thorac Soc 3 (2006) 48-57
50. Cordier J., Valeyre D., Guillevin L., et al. Pulmonary Wegener's granulomatosis. A clinical and imaging study of 77 cases. Chest 97 (1990) 906-912
51. Hoffman G., Kerr G., Leavitt R., et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116 (1992) 488-498
52. Reinhold-Keller E., Beuge N., Latza U., et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 43 (2000) 1021-1032
53. Screaton N., Sivasothy P., Flower C., et al. Tracheal involvement in Wegener's granulomatosis: evaluation using spiral CT. Clin Radiol 53 (1998) 809-815
54. Reuter M., Schnabel A., Wesner F., et al. Pulmonary Wegener's granulomatosis: correlation between high-resolution CT findings and clinical scoring of disease activity. Chest 114 (1998) 500-506
55. Quint L., Whyte R., Kazerooni E., et al. Stenosis of the central airways: evaluation by using helical CT with multiplanar reconstructions. Radiology 194 (1995) 871-877
56. Rosenberg D., Weinberger S., Fulmer J., et al. Functional correlates of lung involvement in Wegener's granulomatosis. Use of pulmonary function tests in staging and follow-up. Am J Med 69 (1980) 387-394
57. Wells A., and Hirani N. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 63 Suppl. 5 (2008) v1-v58
58. Gluth M., Shinners P., and Kasperbauer J. Subglottic stenosis associated with Wegener's granulomatosis. Laryngoscope 113 (2003) 1304-1307
59. Langford C., Sneller M., Hallahan C., et al. Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis. Arthritis Rheum 39 (1996) 1754-1760
60. Polychronopoulos V., Prakash U., Golbin J., et al. Airway involvement in Wegener's granulomatosis. Rheum Dis Clin North Am 33 (2007) 755-775 vi
61. Lee R., and D'cruz D. Novel Therapies for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. Drugs 68 (2008) 747-770
62. Lebovics R., Hoffman G., Leavitt R., et al. The management of subglottic stenosis in patients with Wegener's granulomatosis. Laryngoscope 102 (1992) 1341-1345
63. Stappaerts I., Van Laer C., Deschepper K., et al. Endoscopic management of severe subglottic stenosis in Wegener's granulomatosis. Clin Rheumatol 19 (2000) 315-317
64. Roediger F., Orloff L., and Courey M. Adult subglottic stenosis: management with laser incisions and mitomycin-C. Laryngoscope 118 (2008) 1542-1546
65. Utzig M., Warzelhan J., Wertzel H., et al. Role of thoracic surgery and interventional bronchoscopy in Wegener's granulomatosis. Ann Thorac Surg 74 (2002) 1948-1952
66. Smyth L., Gaskin G., and Pusey C. Microscopic polyangiitis. Semin Respir Crit Care Med 25 (2004) 523-533
67. Savage C., Winearls C., Evans D., et al. Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med 56 (1985) 467-483
68. Hogan S., Nachman P., Wilkman A., et al. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 7 (1996) 23-32
69. Jayne D., Gaskin G., Rasmussen N., et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 18 (2007) 2180-2188
70. Guillevin L., Durand-Gasselin B., Cevallos R., et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 42 (1999) 421-430
71. Brugiere O., Raffy O., Sleiman C., et al. Progressive obstructive lung disease associated with microscopic polyangiitis. Am J Respir Crit Care Med 155 (1997) 739-742
72. Lauque D., Cadranel J., Lazor R., et al. Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Medicine (Baltimore) 79 (2000) 222-233
73. Bargagli E., Madioni C., Olivieri C., et al. Churg-Strauss vasculitis in a patient treated with omalizumab. J Asthma 45 (2008) 115-116
74. Noth I., Strek M., and Leff A. Churg-Strauss syndrome. Lancet 361 (2003) 587-594
75. Choi Y., Im J., Han B., et al. Thoracic manifestation of Churg-Strauss syndrome: radiologic and clinical findings. Chest 117 (2000) 117-124
76. Wechsler M., Pauwels R., and Drazen J. Leukotriene modifiers and Churg-Strauss syndrome: adverse effect or response to corticosteroid withdrawal?. Drug Saf 21 (1999) 241-251
77. Lobel H., Machtey I., and Eldror M. Pulmonary infiltrates with eosinophilia in an asthmatic patient treated with disodium cromoglycate. Lancet 2 (1972) 1032
78. Le Gall C., Pham S., Vignes S., et al. Inhaled corticosteroids and Churg-Strauss syndrome: a report of five cases. Eur Respir J 15 (2000) 978-981
79. Nathani N., Little M., Kunst H., et al. Churg Strauss Syndrome and Leukotriene antagonist use: a respiratory perspective. Thorax (2008)
80. Hauser T., Mahr A., Metzler C., et al. The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case-crossover study. Thorax 63 (2008) 677-682
81. Beasley R., Bibby S., and Weatherall M. Leukotriene receptor antagonist therapy and Churg-Strauss syndrome: culprit or innocent bystander?. Thorax 63 (2008) 847-849
82. Guillevin L., Cohen P., Gayraud M., et al. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine 78 (1999) 26-37
83. Koukoulaki M., Smith K., and Jayne D. Rituximab in Churg-Strauss syndrome. Ann Rheum Dis 65 (2006) 557-559